Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 6/20 | 0.38 |
| ▸ | NPC1 | O15118 | 5/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.36 |
| ▸ | MAPT | P10636 | 4/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 1/20 | 0.36 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.33 |
| ▸ | VDR | P11473 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | OXTR | P30559 | 1/20 | 0.31 |
| ▸ | ACLY | P53396 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13823374 | 0.97 | ALDH1A1 (0.38) | RAB9ANPC1KDM4EMEN1GAA | |
| SCHEMBL13933836 | 0.94 | TSHR (0.40) | RAB9ANPC1KDM4EMEN1GAA | |
| SCHEMBL15358723 | 0.92 | NPC1 (0.42) | RAB9ANPC1KDM4EMEN1GAA | |
| SCHEMBL13203365 | 0.92 | RAB9A (0.40) | RAB9ANPC1KDM4EMEN1GAA | |
| SCHEMBL20932611 | 0.87 | MEN1 (0.47) | RAB9ANPC1KDM4EMEN1GAA | |
| SCHEMBL13843142 | 0.86 | ESR1 (0.36) | ESR1ESR2ALOX15 | |
| SCHEMBL13550842 | 0.85 | — | — | |
| SCHEMBL12162755 | 0.83 | TSHR (0.47) | RAB9ANPC1KDM4EMEN1GAA | |
| SCHEMBL10015232 | 0.82 | NPC1 (0.41) | RAB9ANPC1KDM4EMEN1KMT2A | |
| SCHEMBL40405 | 0.82 | MAPT (0.41) | RAB9ANPC1KDM4EMEN1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159693-A1 | CURABLE COMPOSITIONS CONTAINING ISOCYANATE-BASED TOUGHENERS | KANEKA AEROSPACE LLC (US) | 2023-05-25 | — | — | US | disclosed |
| US-20230159693-A1 | CURABLE COMPOSITIONS CONTAINING ISOCYANATE-BASED TOUGHENERS | KANEKA AEROSPACE LLC (US) | 2023-05-25 | — | — | US | disclosed |
| EP-2969446-B1 | PREPREG CURING PROCESS FOR PREPARING COMPOSITES HAVING SUPERIOR SURFACE FINISH AND HIGH FIBER CONSOLIDATION | Henkel IP & Holding GmbH (DE) | 2022-12-28 | — | — | EP | disclosed |
| US-20210102035-A1 | CURABLE COMPOSITIONS CONTAINING ISOCYANATE-BASED TOUGHENERS | KANEKA AEROSPACE LLC (US) | 2021-04-08 | — | — | US | disclosed |
| EP-2890744-B1 | FLAME-RETARDANT BENZOXAZINE-CONTAINING COMPOSITION | HENKEL AG & CO KGAA (DE) | 2021-02-17 | — | — | EP | disclosed |
| EP-2231743-B1 | CURABLE BENZOXAZINE MACROMONOMERS, THEIR PREPARATION AND CURED PRODUCTS THEREOF | HENKEL AG & CO KGAA (DE) | 2019-05-22 | — | — | EP | disclosed |
| US-20170183450-A1 | CATIONICALLY CURABLE BENZOXAZINE COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2017-06-29 | — | — | US | disclosed |
| US-20170183450-A1 | CATIONICALLY CURABLE BENZOXAZINE COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2017-06-29 | — | — | US | disclosed |
| US-9427943-B2 | Prepreg curing process for preparing composites having superior surface finish and high fiber consolidation | Henkel IP & Holding GmbH (DE) | 2016-08-30 | — | — | US | disclosed |
| US-9427943-B2 | Prepreg curing process for preparing composites having superior surface finish and high fiber consolidation | Henkel IP & Holding GmbH (DE) | 2016-08-30 | — | — | US | disclosed |
| US-20080076886-A1 | Backbones of polyethers, perfluorinated polyethers, polydimethylsiloxanes and hydroxy terminated polybutadienes coupled to phenyl, biphenyl, bisphenol A, bisphenol F, bisphenol S, bisphenol E, allyl, alkyl, alkenyl, carboxy, N-carbamoyl, cyclic amides, epoxy and a thermosetting component; toughening | LOCTITE (R&D) LIMITED | 2008-03-27 | — | — | US | disclosed |
| US-20080076886-A1 | Backbones of polyethers, perfluorinated polyethers, polydimethylsiloxanes and hydroxy terminated polybutadienes coupled to phenyl, biphenyl, bisphenol A, bisphenol F, bisphenol S, bisphenol E, allyl, alkyl, alkenyl, carboxy, N-carbamoyl, cyclic amides, epoxy and a thermosetting component; toughening | LOCTITE (R&D) LIMITED | 2008-03-27 | — | — | US | disclosed |
| US-7312534-B2 | Interlayer dielectric and pre-applied die attach adhesive materials | HENKEL CORPORATION (US) | 2007-12-25 | — | — | US | disclosed |
| US-7312534-B2 | Interlayer dielectric and pre-applied die attach adhesive materials | HENKEL CORPORATION (US) | 2007-12-25 | — | — | US | disclosed |
| US-20070278683-A1 | Interlayer Dielectric and Pre-Applied Die Attach Adhesive Materials | HENKEL CORPORATION (US) | 2007-12-06 | — | — | US | disclosed |
| US-20070278683-A1 | Interlayer Dielectric and Pre-Applied Die Attach Adhesive Materials | HENKEL CORPORATION (US) | 2007-12-06 | — | — | US | disclosed |
| US-20070129509-A1 | Curable compositions | HENKEL CORPORATION | 2007-06-07 | — | — | US | disclosed |
| US-20070129509-A1 | Curable compositions | HENKEL CORPORATION | 2007-06-07 | — | — | US | disclosed |
| US-20070007692-A1 | Curable compositions for advanced processes, and products made therefrom | Henkel IP & Holding GmbH (DE) | 2007-01-11 | — | — | US | disclosed |
| US-20070007692-A1 | Curable compositions for advanced processes, and products made therefrom | Henkel IP & Holding GmbH (DE) | 2007-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070129509-A1 | Curable compositions | CBX4, CBX7, KDM5C | RAB9A 4196/4885NPC1 4543/4885KDM4E 146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.